PMA supplement

P010020 S017: ACTICON NEOSPHINTER

FDA PMA supplement · Normal 180 Day Track · Boston Scientific Corp

Key facts

Original PMA P010020
Supplement number S017
Supplement type Normal 180 Day Track
Trade name ACTICON NEOSPHINTER
Generic name Implanted fecal incontinence device
Applicant Boston Scientific Corp
Product code MIP
Received date Nov 15, 2010
Decision date May 7, 2012

At a glance

  • No Expedited review granted
  • No Approval order on file
  • No Summary of safety and effectiveness on file

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMA supplements

A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.

Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date:

Browse all PMA supplements